Sphera Funds Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-20,000
Closed -$1.62M 112
2023
Q4
$1.62M Sell
20,000
-20,000
-50% -$1.56M 0.26% 78
2023
Q3
$3M Hold
40,000
0.55% 57
2023
Q2
$3.08M Buy
+40,000
New +$3.19M 0.48% 64
2022
Q4
Sell
-105,090
Closed -$6.48M 68
2022
Q3
$6.48M Buy
+105,090
New +$6.63M 0.9% 35
2019
Q4
Sell
-205,000
Closed -$13.3M 92
2019
Q3
$13M Buy
+205,000
New +$13.4M 2.01% 12
2019
Q2
Sell
-480,000
Closed -$31.2M 98
2019
Q1
$31.2M Buy
480,000
+130,000
+37% +$8.64M 2.85% 7
2018
Q4
$21.9M Sell
350,000
-70,000
-17% -$4.89M 2.47% 9
2018
Q3
$32.4M Buy
420,000
+65,000
+18% +$4.91M 3.72% 7
2018
Q2
$25.1M Buy
+355,000
New +$25.1M 3.47% 5
2017
Q4
Sell
-230,000
Closed -$18.6M 139
2017
Q3
$18.6M Hold
230,000
2.66% 5
2017
Q2
$16.3M Buy
+230,000
New +$15.3M 2.77% 7
2016
Q4
Sell
-112,700
Closed -$8.92M 114
2016
Q3
$8.92M Sell
112,700
-80,000
-42% -$6.5M 1.45% 15
2016
Q2
$16.1M Buy
192,700
+20,000
+12% +$1.77M 4.17% 4
2016
Q1
$15.9M Buy
172,700
+30,000
+21% +$2.71M 3.44% 8
2015
Q4
$14.4M Buy
142,700
+22,700
+19% +$2.36M 2.11% 11
2015
Q3
$11.8M Sell
120,000
-200,000
-63% -$22.2M 1.5% 16
2015
Q2
$37.5M Hold
320,000
3.67% 5
2015
Q1
$31.4M Buy
320,000
+130,000
+68% +$13.2M 3.27% 6
2014
Q4
$17.9M Buy
+190,000
New +$19.7M 3.05% 6
2014
Q3
Sell
-50,000
Closed -$4.9M 133
2014
Q2
$4.15M Sell
50,000
-44,000
-47% -$3.42M 1.02% 29
2014
Q1
$6.66M Hold
94,000
1.52% 11
2013
Q4
$7.06M Buy
+94,000
New +$6.55M 1.97% 14

Other funds holding GILD

Sphera Funds Management's GILD Position: Q1 2024 in Review

Sphera Funds Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 20,000 shares — an estimated $1.62M sold.

Sphera Funds Management first reported a position in GILD in Q4 2013 and held it in 22 quarters. The position peaked at $37.5M in Q2 2015. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Sphera Funds Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Sphera Funds Management sold 20,000 Gilead Sciences shares in Q1 2024, an estimated $1.62M.
  • Sphera Funds Management first reported a position in Gilead Sciences in Q4 2013 and held it in 22 quarters.
  • Sphera Funds Management's Gilead Sciences position peaked at $37.5M in Q2 2015.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.